LYEL
Lyell Immunopharma Inc
9.70$
-1.1%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | +1,080.5% | +37.3% | +695.1% | -99.8% | -53.1% | -41.0% | |
| – | – | +94.4% | +13.3% | +23.0% | – | – | |
| – | +1,080.5% | +37.3% | +695.1% | -99.8% | -53.1% | -18,957.4% | |
| – | +186.6% | -23.9% | +14.8% | +14.9% | -6.2% | -7.5% | |
| – | +19.7% | +90.0% | +31.7% | -42.9% | -22.3% | -13.3% | |
| – | +113.8% | +2.6% | +20.5% | -9.1% | +45.2% | -46.4% | |
| – | – | – | – | – | – | – | |
| – | – | -80.4% | – | – | – | – | |
| – | – | – | – | – | – | – | |
| – | – | – | -605.5% | – | – | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.